The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Social Media Campaign for Latin Lupus Sufferers

Social Media Campaign for Latin Lupus Sufferers

January 19, 2018 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

 

You Might Also Like
  • How the Mayo Clinic Maximizes Learning Opportunities Through Social Media
  • Common Sense Tips for Rheumatologists on Social Media
  • Social Media 101 for Rheumatologists & Health Professionals
Explore This Issue
January 2018
Also By This Author
  • Ustekinumab for Behçet’s Disease? The Study Results Are In

A person living with lupus may feel isolated. They receive information from their doctor, but it’s never enough to fully understand the disease. So where do they turn? Social media, where they can connect, share information and learn.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A new social media initiative, Hablemos de Lupus—which translates to Let’s Talk About Lupus—focuses on sharing accurate lupus information with Spanish-speaking patients in Latin America. The focus on Latin America ties in with the proportionally larger number of Latino patients with lupus than non-Latinos. Research shows that a lupus diagnosis usually takes longer to confirm in Latinos than in non-Latinos and the disease tends to be more severe among Latinos.

“Hablemos de Lupus is part of a comprehensive project that aims to bridge a longstanding gap in the provision of appropriate and scalable health education to the Latin American population with lupus,” says Cristina Drenkard, MD, PhD, an associate professor of medicine in the Division of Rheumatology at Emory School of Medicine, Atlanta, who leads the initiative. “The first stage of this initiative targets the Spanish-speaking population with lupus and their caregivers.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Funded by a 2017 International League of Associations for Rheumatology grant, Hablemos de Lupus uses social media as its main vehicle. Its Facebook page has the largest concentration of users, but it also fields a YouTube channel and a Twitter account.

“The social channels provide a safe community where patients can learn from evidence-based content, express themselves, ask [experts] questions and open discussions around lupus with others,” Dr. Drenkard says.

Facebook appears key, says Celeste Eberhardt, social media specialist for Hablemos de Lupus. “Most people have Facebook access and connect to it often. … I was shocked by how relieved people were to see others going through similar experiences,” Ms. Eberhardt says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The Content

Topics covered on Hablemos include general education about lupus and living better with lupus. Videos that last just a couple of minutes and short messages can convey evidence-based information. The group creates its content with the needs and health literacy levels of the audience in mind, Dr. Drenkard says.

Lupus sufferers can check out Hablemos de Lupus on Twitter, Facebook and YouTube.

There’s a special focus on making the videos easy for people to understand, so they aren’t too complex, Ms. Eberhardt says. Videos posted include: “What Is Lupus?” “What Is an Antibody?” and “Exercising with Lupus.” Followers can ask questions, and a team of Hablemos rheuma­tologists answer within 24 hours.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, SLE (Lupus), Technology Tagged With: Lupus, Social Media, TechnologyIssue: January 2018

You Might Also Like:
  • How the Mayo Clinic Maximizes Learning Opportunities Through Social Media
  • Common Sense Tips for Rheumatologists on Social Media
  • Social Media 101 for Rheumatologists & Health Professionals
  • The Role of Social Media in a Rheumatology Practice

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)